Filing Details
- Accession Number:
- 0001019687-10-000265
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-21 12:00:00
- Reporting Period:
- 2010-01-19
- Filing Date:
- 2010-01-21
- Accepted Time:
- 2010-01-21 20:37:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1282393 | Bioform Medical Inc | BFRM | Surgical & Medical Instruments & Apparatus (3841) | 391979642 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1227253 | Biotechnology Development Fund Ii Lp | 575 High Street, Suite 201 Palo Alto, CA 94301 | No | No | Yes | No | |
| 1227254 | Bioasia Mangement Llc | 575 High Street, Suite 201 Palo Alto, CA 94301 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-01-19 | 420,054 | $5.51 | 2,558,713 | No | 4 | S | Indirect | By Biotechnology Development Fund II, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Biotechnology Development Fund II, L.P. |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The reported securities are owned directly by Biotechnology Development Fund II, L.P. and indirectly by BioAsia Management, LLC, as general partner of Biotechnology Development Fund II, L.P. BioAsia Management, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
Billionaire Hedge Funds
